kaposiform hemangioendothelioma
kaposiform hemangioendothelioma
Explore linked clinical trials. Standard reference: MONDO:00162365 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma | kaposiform hemangioendothelioma | Recruiting | Phase 2 | 2026-09-25 | NCT07131644 | |
| Lymphatic Anomalies Registry for the Assessment of Outcome Data | Bone Diseases, Developmental, CLOVES syndrome, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Lymphatic Abnormalities, Osteolysis, Essential, angiomatosis, angioosteohypertrophic syndrome, blue rubber bleb nevus, bone disorder, bone resorption disease, cardiovascular disorder, kaposiform hemangioendothelioma, kaposiform lymphangiomatosis, lymphatic malformation, lymphatic malformation 12, lymphatic system disorder, lytic metastatic bone lesion, musculoskeletal system disorder, tufted angioma, vascular disorder, vascular malformation | Recruiting | Not stated | 2026-09-10 | NCT02399527 | |
| Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP | Cytopenia, Hemic and Lymphatic Diseases, Kasabach-Merritt syndrome, Neoplasms by Histologic Type, blood platelet disease, hemangioma, hematologic disorder, kaposiform hemangioendothelioma, neoplasm, thrombocytopenia, vascular cancer | Recruiting | Phase 2 / Phase 3 | 2026-06-18 | NCT07656909 | |
| The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma | kaposiform hemangioendothelioma | Recruiting | Not stated | 2025-06-27 | NCT05351216 | |
| Identification of Biomarkers for Patients with Vascular Anomalies | Bone Diseases, Developmental, CLOVES syndrome, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Osteolysis, Essential, angiomatosis, angioosteohypertrophic syndrome, bone disorder, bone resorption disease, cardiovascular disorder, diffuse lymphatic malformation, kaposiform hemangioendothelioma, kaposiform lymphangiomatosis, lytic metastatic bone lesion, musculoskeletal system disorder, vascular disorder, vascular malformation | Recruiting | Not stated | 2024-11-06 | NCT03001180 |